Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
New drug shows promise against fatty liver and scarring
Disease control CompletedThis study tested a drug called saroglitazar magnesium in 189 adults with nonalcoholic steatohepatitis (NASH) and liver fibrosis (scarring). The goal was to see if the drug could reduce liver inflammation and scarring without making the disease worse. Participants were randomly a…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New pill shows promise for rare liver disease
Disease control CompletedThis study tested a drug called saroglitazar magnesium in 196 adults with primary biliary cholangitis (PBC), a chronic liver disease. Participants either took the drug or a placebo to see if it improved liver function and reduced itching. The goal was to lower certain liver marke…
Phase: PHASE2, PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC